Bench active · EN ↔ TH · TEL +66 02-859-2145 · NDA from first email · 1-hour quote SLA
EN TH
Request a Proposal

Thai FDA Medical Device Documentation Changes (2024–2025)

What actually changed (no spin) 

1) Full CSDT is now mandatory (Feb 2024). 
“Partial” CSDT routes ended. Class 2–4 notifications/licenses require a complete ASEAN CSDT. If you’re still recycling partial packs at renewal or change, you’re out of spec. Pacific Bridge Medicalcmsmedtech.com 

2) Redundant documents removed (from Jun 6, 2024). 
TFDA cut duplicative items for full evaluations and aligned “concise/reliance” pathways to foreign approvals from recognized agencies—but only when your intended use and labeling are identical to the reference. This is fewer uploads, not “no uploads.” en.fda.moph.go.thEmergo by ULAndaman Medical 

3) “Refer” & “Transfer” are formalized (Sep–Nov 2024). 

  • Refer = new dossier using a prior approved dossier to change brand/name. 

4) Labels/IFU are under a brighter light (Oct 2024 + draft Mar 2025). 
Guidelines now expect complete artwork sets (all panels, variants) and clearer language rules: Thai+EN for home-use, EN acceptable for pro-use (per the 2020 base rule, reiterated in 2024 guidance). Draft amendments (Mar 18, 2025) further tighten presentation; watch finalization. Andaman Medicalasiaactual.com 

5) Change notifications: new matrices (effective Jan 15, 2025). 
For IVDs and non-IVDs, TFDA published case-by-case document grids (add items, accessories, software adjustments, etc.). Pick the correct case or expect a re-work request. Andaman Medical+1qualtechs.com 

What actually changed (no spin) 1) Full CSDT is now mandatory (Feb 2024).

Thai FDA Medical Device Documentation Changes (2024–2025)

Who this hits (and how) 

  • Manufacturers (Class 1–4): re-baseline to Full CSDT and artwork-accurate labels/IFU. 
  • Importers/License holders: prep Refer/Transfer packs when brands or entities change; align Thai/EN company names and addresses everywhere. 
  • IVD companies: map changes to the Jan-2025 matrices; don’t over- or under-submit. Andaman Medical+1 

The translation spec that clears TFDA review (TH ↔ EN) 

CSDT core (Class 2–4): 
Executive Summary, Essential Principles checklist, Risk-Management summary, V&V summary, Clinical evidence synopsis, Manufacturing info, DoC, LoA, and labeling/IFU. Use one terminology across every section and attachment. Pacific Bridge Medical 

Label/IFU packs: 

  • Upload full packaging artwork (primary → shipper), each model/pack-size separately. 
  • Language: home-use = TH+EN; professional-use = EN acceptable, but keep Thai importer details correct. 
  • Images must be readable; performance/claims may trigger data requests. Andaman Medical 

Reliance/concise submissions: 
Only if your intended use + IFU + labels are identical to the recognized foreign approval. One “creative” Thai rephrase can break reliance. Emergo by UL 

Refer/Transfer: 
Prepare bilingual Declaration of Identicality (คำชี้แจงความเหมือน), consent letters, and cross-references to the original license number; ensure company names/addresses match across label/IFU/DoC. Andaman Medical 

Change notifications (IVD & non-IVD): 
Match the TFDA case type; attach only what the grid requires (e.g., comparison tables, updated labels/IFU, targeted V&V). Don’t flood the portal with extras that contradict your summary. Andaman Medical+1 

Avoidable rejection triggers (we see these weekly) 

  • Indications drift between your reliance reference and Thai texts. (Reliance void.) Emergo by UL 
  • Artwork gaps: only one panel uploaded; tiny unreadable images; variants not filed separately. Andaman Medical 
  • Wrong change-matrix case → wrong document set → delay. qualtechs.com 
  • Entity/brand changes without a Refer/Transfer path and identicality proof. Andaman Medical 

Cut-through timeline (pin this in your RA tracker) 

  • Sep–Oct 2024 — Refer/Transfer processes announced with visuals. Andaman Medical 
  • Oct 11, 2024 — Label attachment guidance (artwork, images, variants). Andaman Medical 
  • Jan 15, 2025 — New change-notification matrices take effect (IVD; later mirrored for non-IVD). Andaman Medical+1 
  • Mar 18, 2025 — Draft label/IFU amendments published (monitor final). asiaactual.com 

“Ready-to-file” checklist (copy/paste) 

  • Full CSDT in EN with TH mapping for critical fields (device name, intended use). 
  • Label/IFU artwork: all panels, each variant; TH+EN for home-use; importer/manufacturer details exact. Andaman Medical 
  • Reliance pack (if used): reference approval + identical indications/IFU/labels. Emergo by UL 
  • Refer/Transfer: Declaration of Identicality (TH/EN), consent letters, prior license refs. Andaman Medical 
  • Change case (IVD/non-IVD): choose matrix category; add comparison table + updated docs only. Andaman Medical+1 

How Othello keeps your file moving 

  • Bilingual CSDT builds with locked terminology across ES/EP/RM/V&V/clinical. 
  • Artwork-first label/IFU packs (all panels, variant mapping, readability checks). Andaman Medical 
  • Reliance policing (we reject wording that would break “identicality”). Emergo by UL 
  • Refer/Transfer dossiers (TH/EN identicality declarations, consents, cross-refs). Andaman Medical 
  • Change-matrix kits (cover letters, comparison tables, target docs per Jan-2025 grids). Andaman Medical 

CTA: Send your current label/IFU set and intended use. We’ll map it to TFDA’s current pathways and tell you—plainly—what to keep, fix, or scrap before you file. 

Sources (official/regulatory-grade) 

  • Thai FDA announcement reducing redundant tech docs (effective June 6, 2024). en.fda.moph.go.th 

Othello International is a Bangkok-based bilingual (EN↔TH) technical translation and ESG advisory firm. Related specialist services:

Talk to the bench

Bilingual ESG disclosure, certified translation and interpretation for SET-listed Thailand — one NDA, one accountable in-house team.

Get in touch
Before your next disclosure cycle

See where your English edition is losing FTSE points.

A free Gap Audit maps your published English disclosure against FTSE Russell’s 14 themes — and shows exactly which gaps are quietly costing you points, index inclusion and investor attention.

ISO 17100 · NDA from the first email · 100% in-house Bangkok bench
Facebook
Twitter
LinkedIn
WhatsApp
Get Free Quote

Answers

Frequently asked questions

What medical-device documents does Thai FDA registration require in Thai?
Registration with Thailand's FDA typically requires product documentation, such as technical files, instructions for use, labeling, and supporting certificates, to be submitted in line with Thai regulatory requirements, often in Thai. Accuracy is critical because mistranslation of technical or clinical content can delay approval. Othello provides certified technical and medical translation for device documentation under NDA.
How should manufacturers handle recent changes to Thai FDA medical-device documentation rules?
When documentation requirements are updated, existing files, labeling, and instructions for use may need to be revised and re-translated to stay compliant, and manufacturers should confirm the current requirements with the Thai FDA or a regulatory specialist. Keeping terminology consistent with previously approved submissions helps avoid new queries. Othello re-translates and aligns updated device documentation while preserving established terminology.
Do medical-device translations need to be certified?
Regulatory submissions often call for certified translations so the authority can rely on the accuracy of technical and clinical content, and requirements vary by document type. Othello is an ISO 17100-certified firm and provides certified translation suitable for regulatory use, handled by translators experienced with medical and technical material. Confirming the exact certification format with the receiving authority is always advisable.
FTSE 2026 PlaybooksFree ESG disclosure guides
Chat on LINEแอดไลน์ · ตอบใน 1 ชม.
Add Othello ESG on LINE (QR code)
แอดไลน์ · Add us on LINE
Scan to chat with Othello ESG on LINE — a reply within one business hour, under NDA from the first message.
Open LINE →
Recognised & delivered Credited in DLA Piper × UK PACT × DCCE’s carbon-pricing report · SET JUMP+ Advisory Pool listed advisor · FTSE Russell 4.0/5.0 delivered · ISO 17100 certified
Get a 1-hour quote →

Research & Reports

Free Tools

ISSB Training

· YouTube
Free tools & research State of ESG Disclosure· ESG Rating Check· FTSE 2026 Playbooks· Regulation Radar· Greenwashing Checker